Efficacy and safety of Shufeng Huashi formula for post-infectious cough: study protocol for a randomized control trial - Takeaways - MDSpire

Efficacy and safety of Shufeng Huashi formula for post-infectious cough: study protocol for a randomized control trial

  • By

  • Xinyi Zhang

  • Yirun Li

  • Yuxin Han

  • Hongchun Zhang

  • June 1, 2026

  • 0 min

Share

  • 1

    The study evaluates the effectiveness and safety of the Shufeng Huashi formula for treating post-infectious cough in a randomized controlled trial.

  • 2

    A total of 120 patients aged 18–65 will be recruited and randomly assigned to receive either the SFHS formula or a placebo.

  • 3

    Primary outcome measures include cough relief rate on day 14, with secondary measures assessing various cough symptom scores and recurrence rates.

  • 4

    The trial aims to provide evidence for Traditional Chinese Medicine's efficacy in treating post-infectious cough, addressing current treatment limitations.

  • 5

    The study will be conducted across six hospitals in China, with a timeline from November 2024 to November 2027 for participant recruitment and intervention.

Original Source(s)

Efficacy and safety of Shufeng Huashi formula for post-infectious cough: study protocol for a randomized control trial

  • by Xinyi Zhang, Yirun Li, Yuxin Han, Hongchun Zhang

  • June 1, 2026

Related Content

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains

Management of toxicities from antibody – drug conjugates in breast cancer

Effects of modified uvulopalatopharyngoplasty combined with pharyngeal and genioglossus exercises on sleep quality, cognitive function, and quality of life in patients with obstructive sleep apnea-hypopnea syndrome: a retrospective study